183 related articles for article (PubMed ID: 28728843)
1. Expression and prognostic role of orphan receptor GPR110 in glioma.
Shi H; Zhang S
Biochem Biophys Res Commun; 2017 Sep; 491(2):349-354. PubMed ID: 28728843
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.
Liu Z; Zhang G; Zhao C; Li J
Med Sci Monit; 2018 Jul; 24():5216-5224. PubMed ID: 30052620
[TBL] [Abstract][Full Text] [Related]
3. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
4. CTR9-mediated JAK2/STAT3 pathway promotes the proliferation, migration, and invasion of human glioma cells.
Xu Y; Chen J; He G; Zhang Y
J Clin Lab Anal; 2021 Sep; 35(9):e23943. PubMed ID: 34369006
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer.
Zhu X; Huang G; Jin P
Pathol Res Pract; 2019 Mar; 215(3):539-545. PubMed ID: 30638950
[TBL] [Abstract][Full Text] [Related]
6. GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer.
Bhat RR; Yadav P; Sahay D; Bhargava DK; Creighton CJ; Yazdanfard S; Al-Rawi A; Yadav V; Qin L; Nanda S; Sethunath V; Fu X; De Angelis C; Narkar VA; Osborne CK; Schiff R; Trivedi MV
Breast Cancer Res Treat; 2018 Jul; 170(2):279-292. PubMed ID: 29574636
[TBL] [Abstract][Full Text] [Related]
7. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
[TBL] [Abstract][Full Text] [Related]
8. ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis.
Li J; Shen J; Wang Z; Xu H; Wang Q; Chai S; Fu P; Huang T; Anas O; Zhao H; Li J; Xiong N
Sci Rep; 2019 Sep; 9(1):13904. PubMed ID: 31554859
[TBL] [Abstract][Full Text] [Related]
9. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L
Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367
[TBL] [Abstract][Full Text] [Related]
10. Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer.
Lum AM; Wang BB; Beck-Engeser GB; Li L; Channa N; Wabl M
BMC Cancer; 2010 Feb; 10():40. PubMed ID: 20149256
[TBL] [Abstract][Full Text] [Related]
11. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.
Song C; Fan B; Xiao Z
Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p.
Hu D; Zhang Y
Gene; 2019 Mar; 690():81-89. PubMed ID: 30576808
[TBL] [Abstract][Full Text] [Related]
14. ACYP2 contributes to malignant progression of glioma through promoting Ca
Li M; Ruan B; Wei J; Yang Q; Chen M; Ji M; Hou P
J Exp Clin Cancer Res; 2020 Jun; 39(1):106. PubMed ID: 32517717
[TBL] [Abstract][Full Text] [Related]
15. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
16. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
17. Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-γ and STAT3 protein signaling pathways.
Ou Y; Ma L; Dong L; Ma L; Zhao Z; Ma L; Zhou W; Fan J; Wu C; Yu C; Zhan Q; Song Y
J Biol Chem; 2012 Sep; 287(39):32394-405. PubMed ID: 22843679
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
[TBL] [Abstract][Full Text] [Related]
19. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
20. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
